Company Analysis
Sign in

Progyny, Inc. (PGNY)

Nasdaq: PGNY · Services-Misc Health & Allied Services, NEC · New York, NY · filing with the SEC since 2012
Full chart Alerts Compare
Grade6.6
◀ Past 8.4● Present 6.3▶ Future 5.2
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyfiscal 2025, as filed
Revenue$1.29B+10.4%
Net income$58.5M+7.7%
Earnings per share$0.65+14.0%
Operating cash flow$210M+17.4%
Cash$112M-30.9%
Debtn/a
Shareholders’ equity$516M+22.3%
Shares, diluted89.9M-5.9%
Return on equity11.3%
The recordfrom its filings
Filings in 202694
Newest filingNov 12 · 144
Annual reportFeb 27, 2026
Quarterly reportNov 5, 2026
Next report due10-K by Mar 1
Insider sales, 12 months$24.5M
Insider buys, 12 months$1.9M
Patents granted4
Filer categoryLarge accelerated filer
Trailing twelve months to Sep 2026Revenue $1.34BNet income $91.0MCash from operations $207Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 12, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 6, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton PGNY · research, not advice